CTOs on the Move

Vericast

www.vericast.com

 
Every day, we influence where more than 120 million households eat, shop, buy, save and borrow
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Haripriyan Vijayakumar
VP Engineering, Data Strategy and Operations Profile
Sammy Natour
Chief Technology Officer Profile
Jim Swayze
Executive Director, Information Security Profile
Jim Swayze
Chief Information Security Officer Profile
Jason Ayers
Chief Information Security Officer Profile

Similar Companies

TRAVIZON Inc.

At Travizon, our mission is to create unsurpassed value and the highest level of customer satisfaction within our business relationships.

EQ Solutions

EQ Solutions is a Albany, OR-based company in the Business Services sector.

Cornerstone Systems

Recognized for our exceptional customer experience, Cornerstone Systems is a leading nationwide provider of solutions for transportation and logistics. We offer intermodal, railcar & railcar consolidation, truck brokerage, container drayage, LTL, supply chain solutions, on-site logistics, warehousing & transloading services, and more. As a nationally recognized award winning company, with service coverage that spans all of North America, Cornerstone`s proven professionals vow to offer Rock Solid Transportation Solutions. Count on Cornerstone – The Clear Choice – for Rock Solid Results. An Employee Owned Company. U.S. EPA SmartWay Transport Partner. Better Business Bureau A+ Rating.

DRI Healthcare

DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Over the course of three decades, we have been a trusted partner of royalty sellers and demonstrated strong execution, building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. That foundation sets us apart as we continue developing solutions for innovators while building and managing a risk-mitigated portfolio of therapeutic assets that generates attractive returns and growth potential for investors. We have deployed more than $2.5 billion, acquiring more than 70 royalties on 40-plus drugs.